Clinical Trial

Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department

Study acronym: ACUTE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this proposal is to improve the quality and value of care for patients with acute chest pain by investigating the potential impact of point-of-care (POC) high sensitivity cardiac troponin (hs-cTn) testing in the Emergency Department (ED) and exploring how best to integrate POC hs-cTnl into ED risk stratification workflows. The study hypothesizes that the Abbott i-STAT POC hs-cTnI assay will decrease time-to-result (TTR) and ED length of stay (LOS), while increasing ED revenue for patients with acute chest pain compared to a strategy of central laboratory hs-cTnI testing.
Protocol Amendment History 1 change
minor Completion pushed: 2026-07 -> 2026-12 2026-07-30
Trial Details
NCT Number NCT06899776
Lead Sponsor Wake Forest University Health Sciences
Collaborators: Abbott Point of Care
Conditions ACS (Acute Coronary Syndrome)
Enrollment 600 participants
Start Date 2025-02-07
Primary Completion 2025-09-15 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-29